Clinical Conditions Flashcards
What is Marfan’s syndrome?
Autosomal dominant disorder where expression of fibrillin gene is abnormal therefore elastic tissue is abnormal
Sufferers are abnormally tall, exhibit arachnodactyly, have frequency joint dislocation and can be at risk of catastrophic aortic rupture
What is marasmus?
Severe malnutrition characterised by energy deficiency
What is Kwashiorkor?
Protein-energy malnutrition causing oedema of the abdomen
What is hyperlactaemia and lactic acidosis?
Hyperlacteamia - lactate level 2-5mM (below renal threshold)
Lactic acidosis - lactate level >5mM (above renal threshold - lowers blood pH)
What is cushing’s syndrome?
Excess cortisol (corticosteroids) which stimulates the increased breakdown of protein
What is the basis of refeeding syndrome?
Urea cycle involves 5 enzymes, these enzymes are down regulated during starvation as there is no ammonia to remove. When feeding starts again there is a build up of ammonia causes toxicity as the enzymes cannot remove the ammonia
What is PKU and describe the metabolic pathway?
Phenylketonuria - excess phenlyketones excreted in urine
Autosomal recessive genetic disorder
Phenylalanine —> tyrosine (phenylalanine hydroxylase) —> Noradrenaline, adrenaline, dopamine
PKU there is no/reduced enzyme (phenylalanine hydroxylase
Alternative pathway phenylalanine —> phenylpyruvate
What is homocystinuria?
Excess homocystine in urine (oxidised form of homocysteine)
Autosomal recessive genetic disorder
Homocysteinie —> cystathionine (CBS) —> cysteine
No/reduced CBS
Alternative pathway homocysteine —> methionine (Vit B12)
What is hyperlipoproteinaemia, why does this occur and what are the clinical signs?
Raised levels of lipoproteins
Causes: over-production/underremoval
Due to defective: enzymes, receptors, apoproteins
Clinical signs: Xanthelasma (cholesterol deposits on eye lids), tendon xanthoma (accumulation of lipid in tendons), corneal arcus
How does an atheroma form?
Oxidised LDL - Macrophages (engulfs faulty LDL) - foam cells - accumulate in cell wall - fatty streak - atheroma (plaque formation)
What happens during a toxic dose of paracetamol?
Phase 2 pathway (liver conjugation by glutathione) becomes inundated, causing metabolism by alternative pathway.
N-acetyl-p-benzo-quinone imine (NAPQI) is formed, which can be inactivated by glutathione, but when levels of glutathione reach 30% NAPQI reacts with nucleophilic aspects of cell leading to necrosis.
How does chronic alcohol toxicity occur and what is the treatment?
Excess NADH stimulates fat deposition (alcohol + NAD+ —> acetaldehyde + NADH)
Acetaldehyde damages liver cells (hepatocytes)
Treatment - Disulfiram (inhibitor of aldehyde dehydrogenase)
Describe diabetes mellitus type 1
Diabetes mellitus - chronic hyperglyceamia (prolonged elevation of blood glucose), associated with elevate glucose levels in urine (blood glucose level higher than renal threshold)
Fasting >7.0mM
Random >11.1mM
Type 1 - inability to produce sufficient insulin (loss of beta-cells), can be autoimmune or non-autoimmune, rapid onset, presence of ketones in urine
Describe diabetes mellitus type 2
Diabetes mellitus - chronic hyperglyceamia (prolonged elevation of blood glucose), associated with elevate glucose levels in urine (blood glucose level higher than renal threshold)
Fasting >7.0mM
Random >11.1mM
Type 2 - normal or increased insulin secretion but relative insulin resistance (defective insulin receptor mechanism, defective post-receptor events) - associated with obesity, absence of ketones in urine (signifies that beta-cells are sill producing some insulin)
Long term complications - muscle wasting & weight loss, hyperglyceamia, ketosis
What are the consequences of untreated diabetes mellitus?
Hyperglyceamia - polyuria and polydipsia becuase glucose exceeds renal threshold, blurring of vision, urogenital infections
inadequate energy utilisation - tiredness, weakness, weight loss
Chronic microvascular - eye disease (retinopathy), nepthropathy, neuropathy
Chronic macrovascular - coronary artery disease, stroke, poor peripheral circulation
Describe diagnosis of diabetes
Fasting venous glucose (>7.0mmol/L)
Random venous plasma glucose (>11.1mmol/L)
Oral glucose tolerance test
HbA1c
What is the treatment for diabetes mellitus
Type 1 - insulin
Type 2 - lifestyle, metformin (non-insulin therapies), insulin
Describe Addison’s disease
Hypoactivity of adrenal cortex
- Diseases of the adrenal cortex (auto-immune destruction) - reduces glucocorticoids and mineralcorticoids
- Disorders in pituitary or hypothalamus that lead to decreases secretion of ACTH or CRH - only affects glucocorticoids
Describe Cushing’s disease
Hyperactivity of the adrenal cortex
- Tumour causing hyperactivity (adenoma)
- Disorders in secretion of ACTH caused by pituitary adenoma (Cushing’s disease) or ectopic secretion of ACTH
What are the signs and symptoms of excess cortisol?
Hyperglyceamia causing polyuria and polydipsia (increased proteolysis and hepatic gluconeogenesis)
Wasting of proximal muscles producing thin arms and legs (increased muscle proteolysis)
Fat deposition in abdomen, neck and face (increased lipogenesis in adipose tissue)
Purple striae on lower abdomen, upper arms and thighs (catabolic effects on protein structures in skin)
What can increased pigmentation be a sign of?
Decreased cortisol
Negative feedback causes increased production of ACTH which in turn increases alpha-MSH secretion.
Describe the clinical tests for adrenocorticol function
Plasma cortisol and ACTH level
24hr urinary excretion of cortisol
Dexamethasone suppression test - Exogenous steroid that provides negative feedback to the pituitary to suppress ACTH and CRH release
Describe the dexamethasone suppression test and its results
Used for diagnosis of adrenocorticol disease
Exogenous steroid that provides negative feedback to pituitary to suppress ACTH and CRH release
Can be high dose or low dose tests
Low dose - normal response would be a reduction in cortisol level
Cushing’s disease (pituitary adenoma —> hyperactivity) is shows no decrease of cortisol in low dose test but reduction in high dose test
If no response is shown by either low dose or high dose then other causes of cushing’s syndromes must be investigated.